Orchid Pharma Ltd has received ANDA approval from US FDA for Risedronate Sodium Tablets USP, 30 mg and 35 mg today.
Risedronate Sodium Tablets are bisphosphonate indicated for the treatment and prevention of Osteoporosis.
Shares of Orchid Pharma Ltd was last trading in BSE at Rs.3.83 as compared to the previous close of Rs. 4.03. The total number of shares traded during the day was 36490 in over 54 trades.
The stock hit an intraday high of Rs. 4 and intraday low of 3.83. The net turnover during the day was Rs. 139984.